A doping violation has caused India opening batsman Pritvhi Shaw to be suspended until 15 November 2019.
Shaw was not named in the squad for next month’s Test series against the West Indies due to a hip injury, but also won’t be allowed to play against South Africa in October or November’s first Test versus Bangladesh.
The 19-year-old’s urine sample, required by the Board of Control for Cricket in India’s anti-doping testing programme, tested positive for Terbutaline.
‘Terbutaline, a specified substance, is prohibited both in and out of competition in the World Anti-Doping Agency prohibited list of substances,’ read a statement from the BCCI.
‘Shaw inadvertently ingested a prohibited substance, which can be commonly found in cough syrups. Because he promptly admitted his anti-doping rule violation upon being confronted with it by the BCCI, there is discretion under BCCI anti-doping rules article 10.10.2 to backdate the start of the period of ineligibility to the date of sample collection [22 February 2019].
“However, the BCCI ADR article 10.10.2 also requires him to actually serve one half of the period of ineligibility. Therefore, further to BCCI ADR article 10.10.2, the eight-month period of ineligibility will be deemed to have started to run on 16 March 2019, so that it will end at midnight on 15 November 2019.’
— Prithvi Shaw (@PrithviShaw) July 30, 2019
Shaw debuted in international cricket late last year and averages over 118 after two Tests. He was also a key member of the Delhi Capitals’ 2019 Indian Premier League campaign.
Photo: Getty Images
